Evaluation of fibrin-modulating nanogels for treatment of DIC in COVID-19
- Funded by North Carolina Biotechnology Center
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$20,000Funder
North Carolina Biotechnology CenterPrincipal Investigator
Ashley BrownResearch Location
United States of AmericaLead Research Institution
North Carolina State UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
This project evaluates a novel nanogel therapeutic to treat Disseminated Intravascular Coagulation (DIC), a pathological process associated with higher mortality rates in COVID-19 patients.